| Value | ₹500.0 Cr |
|---|
NSE filing, NSE: SPCENET. Summary written from the filing by ALFA Finder's alert engine.
Spacenet Enterprises India Ltd: key numbers
- Share price
- ₹3.14
- Market cap
- ₹178.5 Cr
- Revenue (annual)
- ₹194.7 Cr
- Net profit (annual)
- ₹16.07 Cr
- P/E (TTM)
- 7.1×Sector 23.5×
- Promoter holding
- 15.50%-0.02% QoQ
- FII holding
- 1.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Spacenet Enterprises India Ltd
All →Spacenet Enterprises India Annual General Meeting
Spacenet Enterprises held its 16th AGM on September 29, 2026, where shareholders considered financial statements, director appointments, related-party transactions, and a fund-raise approval.
Spacenet Enterprises India Results Correction
Spacenet Enterprises clarifies that a mismatch in Standalone EPS within its XBRL filing was due to a clerical data entry error. No financial results were changed.
Spacenet Enterprises India Employee Stock Options
Spacenet's NRC re-granted 6,02,500 ESOPs and allotted 6,04,500 equity shares at ₹1 each. The options vest over four years under the 2021 scheme.
Spacenet Enterprises India Annual General Meeting
Spacenet Enterprises India Limited issued notice for its 16th Annual General Meeting on September 29, 2026. Agenda covers financial adoption, director appointments, related-party transactions, and fund-raising approval.
Spacenet Enterprises India Annual Report
Spacenet Enterprises India Limited has submitted its 16th Annual Report for FY 2025-26 and the Notice of the 16th Annual General Meeting.
Spacenet Enterprises India Q1 FY27 Results: Net Profit ₹13.8 Cr, Up 263.2% YoY
Spacenet Enterprises India Ltd reported revenue from operations of ₹48.9 Cr (-8.4% YoY) and net profit of ₹13.8 Cr (+263.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹13.8 Cr · +263.2% YoY
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr